监测访问社区药房的患者对抗微生物药物的认识

Kosuke Hasegawa1, Yuriko Matsumura2, Tomoko Mori2

  • 1Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan; MEDIX, Inc, 1-2-3 Motoyokoyamacho, Hachioji, Tokyo, 192-0063, Japan; Shinwa Pharmacy Shincho Store, 101 Iwasaki Building 7-12 Shincho, Hachioji, Tokyo, 192-0065, Japan.

概括

许多患者缺乏对抗微生物耐药性 (AMR) 的认识,并滥用抗微生物药物. 医生和药剂师教育对于改善抗微生物药物的使用和打击AMR至关重要.

相关概念视频

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K